Bristol-Myers Squibb Co
BMV:BMY

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
BMV:BMY
Watchlist
Price: 980 MXN -4.67% Market Closed
Market Cap: 102.8B MXN

Profitability Summary

Bristol-Myers Squibb Co's profitability score is 60/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

60/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

60/100
Profitability
Score
60/100
Profitability
Score

Margins

Earnings Waterfall
Bristol-Myers Squibb Co

Margins Comparison
Bristol-Myers Squibb Co Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Bristol-Myers Squibb Co
NYSE:BMY
112.5B USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.8B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.2B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.5B AUD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Bristol-Myers Squibb Co Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Bristol-Myers Squibb Co
NYSE:BMY
112.5B USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
378.8B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.8B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
222.2B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
155.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
112.1B USD
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
85.5B AUD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Bristol-Myers Squibb Co

Last Value
3-Years Average
FCF Margin
Conversion Rate